logo

Quick Facts

Share SHARE

HanesBrands (HBI) announced it expects to report third-quarter net sales of approximately $1.80 billion, EPS of approximately $0.55, and adjusted EPS of approximately $0.60. Analysts polled by Thomson Reuters expect the company to report profit per share of $0.60 on revenue of $1.8 billion, for the quarter....

UniFirst Corporation (UNF) announced the company now expects fiscal 2018 revenues will be between $1.625 billion and $1.645 billion and full year earnings per share will be between $5.00 and $5.30. In June, the company projected its full year revenues will be between $1.573 billion and $1.580 billion...

While reporting its third-quarter financial results on Wednesday, Abbott Laboratories (ABT) narrowed its outlook for fiscal 2017 adjusted earnings per share and also forecast adjusted earnings for the fourth quarter mostly below analysts' estimates. Abbott now projects full-year earnings from continuing...

RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (ALNY) announced Wednesday a licensing agreement with Vir Biotechnology for the development and commercialization of RNAi therapeutics for infectious diseases, including chronic hepatitis B virus or HBV infection. Under the deal terms, Alnylam...

Merck (MRK) announced the presentation of updated overall survival findings, a secondary endpoint, from the phase 3 KEYNOTE-024 trial evaluating KEYTRUDA (pembrolizumab), the company's anti-PD-1 therapy, as a first-line monotherapy in patients with non-small cell lung cancer (NSCLC) whose tumors express...

Qudian Inc. (QD), a provider of online small consumer credit products in China, today announced the pricing of its initial public offering of 37.50 million American depositary shares at a price to the public of US$24.00 per ADS for a total offering size of approximately US$900.00 million, assuming the...

Eli Lilly and Co. (LLY) announced Wednesday a global immuno-oncology collaboration with CureVac AG focused on the development and commercialization of up to five potential cancer vaccine products based on CureVac's proprietary RNActive technology. The companies will use messenger RNA or mRNA technology...

Bell, Canada's largest communications company wholly owned by BCE Inc. (BCE, BCE.TO), and Akamai Technologies Inc. (AKAM), announced a strategic partnership that expands Bell's broad portfolio of web security solutions for Canadian businesses with the addition of Akamai's web performance and cloud security...

SUPERVALU INC. (SVU) announced the company currently expects its fiscal 2018 net earnings from continuing operations to be in the range of $31 million to $50 million. Adjusted EBITDA, including the contribution from Unified Grocers, is expected to be in the range of $475 million to $495 million. Previously,...

Assurant, Inc. (AIZ), a provider of risk management solutions, announced Wednesday its agreement to acquire Warranty Group, a provider of protection plans and related programs,and a portfolio company of TPG Capital. The transaction values Warranty Group at $1.9 billion in equity value, or $2.5 billion...

Radian Group Inc. (RDN) provided an update on strategic actions. It has eliminated the position of president of the Services business. As a result, Jeff Tennyson will step down from the role effective immediately. On October 16, 2017, Radian entered into a three-year, $225 million unsecured revolving...

CVS Health (CVS) announced a five-year agreement with Anthem Inc. (ANTM) to provide services to support IngenioRx, a new pharmacy benefit manager (PBM) announced today by Anthem. As part of the agreement, CVS Caremark will manage certain services for IngenioRx, including claims processing and prescription...

EnCana (ECA, ECA.TO) said that, through its five-year plan, the company expects its return on capital employed will climb to between 10 to 15 percent. In addition, Encana expects to deliver approximately 25 percent compound annual growth in non-GAAP cash flow and around $1.5 billion of cumulative non-GAAP...

UK Consumer goods giant Reckitt Benckiser plc (RBGLY, RB.L) reported Wednesday that its third-quarter net revenue was 3.21 billion pounds, 30 percent higher than last year. The results were benefited from positive FX impact and the acquisition of Mead Johnson Nutrition. On a like-for-like basis, net...

AstraZeneca plc (AZN.L, AZN) and Merck & Co. Inc. announced the US FDA has accepted and granted priority review for a supplemental New Drug Application (sNDA) for the use of Lynparza (olaparib) tablets in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer who have been previously...

Follow RTT